Sheldon, E., Kitchin, N., Peng, Y., Eiden, J., Gruber, W., Johnson, E., . . . Pedneault, L. (2016). A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults. Vaccine, 34(18), 2082-2091. https://doi.org/10.1016/j.vaccine.2016.03.010
Chicago Style (17th ed.) CitationSheldon, Eric, Nicholas Kitchin, Yahong Peng, Joseph Eiden, William Gruber, Erik Johnson, Kathrin U. Jansen, Michael W. Pride, and Louise Pedneault. "A Phase 1, Placebo-controlled, Randomized Study of the Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Vaccine Administered with or Without Aluminum Hydroxide in Healthy Adults." Vaccine 34, no. 18 (2016): 2082-2091. https://doi.org/10.1016/j.vaccine.2016.03.010.
MLA (9th ed.) CitationSheldon, Eric, et al. "A Phase 1, Placebo-controlled, Randomized Study of the Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Vaccine Administered with or Without Aluminum Hydroxide in Healthy Adults." Vaccine, vol. 34, no. 18, 2016, pp. 2082-2091, https://doi.org/10.1016/j.vaccine.2016.03.010.